ABSTRACT SUBMISSIONS POSTPONED
TO JULY 15, 2022
Pre-Clinical Development at Eurofarma: how a Brazilian Pharmaceutical Company is investing in Drug Discovery?
Abstract: The Drug Discovery team is part of Eurofarma’s Innovation Unit that, since 2015, has been working towards expanding the company’s scope of operations at national and international levels. Located inside Eurolab, which accommodates more than 500 researchers totally dedicated to R&D, is an unprecedented ecosystem within the pharmaceutical companies in Brazil. Our main goal is the identification and development of innovative drugs to attend to the innumerous unmet medical needs, focused on specific therapeutic areas, such as bacterial and parasitic Infections, pain, mood disorders, and inflammation. Led by Dr. Gabriela Barreiro, our team is currently composed of synthetic organic chemists, computational chemists, biochemists, pharmacologists, and biologists, working side-by-side to address the different challenges of drug discovery programs.